Biotech Stocks Tumble As FDA Doubts Method Of Testing Drugs [Investor's Business Daily]
Gilead Sciences, Inc. (GILD)
Last gilead sciences, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.gilead.com
Company Research
Source: Investors Business Daily
Related news 6/04/2019 Gilead is one of the biggest biotech companies. But recent news and earnings have been mixed. So, is Gilead stock... Allergan Fended Off Botox Rivalries In The First Quarter — But Can It Last? Is Gilead Stock Seeing The Light Of O'Day? HIV Drugs Bolster Views Is Gilead's Former Golden Goose Stabilizing? Here's What Earnings Say Gilead Reverses After Liver-Disease Treatment Fails Its Second Key Test How This Biotech Giant Is Using Machine Learning In Liver Disease Could This Backing Help Allergan's CEO Retain His Chairman Role? Novartis Snags A $1.6 Billion Buy That Could Rival These Biotechs Stocks Showing Market Leadership: Viking Therapeutics Earns 93 RS Rating Biotech stocks Intercept Pharmaceuticals ( ICPT ) and Madrigal Pharmaceuticals ( MDGL ) were slugged Thursday after the Food and Drug Administration cast doubt on a method of evaluating some liver disease drugs. On today's stock market , Intercept stock toppled 5.
Show less
Read more
Impact Snapshot
Event Time:
GILD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GILD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GILD alerts
High impacting Gilead Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
GILD
News
- 5 Biotech Stocks Worth Adding to Your Portfolio in 2024 [Yahoo! Finance]Yahoo! Finance
- RedHill Announces New Opaganib Chinese Patent Against Ebola Virus Valid Through 2035 [Yahoo! Finance]Yahoo! Finance
- Forbes Has Listed Gilead as One of America's Best Employers for Diversity [Yahoo! Finance]Yahoo! Finance
- Gilead Sciences, Inc. (NASDAQ: GILD) had its price target lowered by analysts at Maxim Group from $90.00 to $85.00. They now have a "buy" rating on the stock.MarketBeat
- Gilead Sciences to Present at Upcoming Investor ConferencesBusiness Wire
GILD
Earnings
- 4/25/24 - Beat
GILD
Sec Filings
- 4/26/24 - Form 4
- 4/25/24 - Form 8-K
- 4/2/24 - Form 4
- GILD's page on the SEC website